{
  "tool": "tavily",
  "query": "abridge company total_raised_usd",
  "results": [
    {
      "title": "Healthcare startup Abridge tops $5 billion valuation in A16z-led ...",
      "content": "Healthcare firm Abridge, which uses artificial intelligence to build medical documents, has raised $300 million at a $5.3 billion valuation.",
      "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-startup-abridge-raises-300-million-led-by-vc-firm-andreessen-horowitz-2025-06-24/"
    },
    {
      "title": "AI Note-Taking Startup Abridge Raises $300M As Tech To Reduce ...",
      "content": "# AI Note-Taking Startup Abridge Raises $300M As Tech To Reduce Physician Burnout Gains Traction Abridge, a startup that offers an AI note-taking tool for doctors, raised $300 million at a $5.3 billion valuation, according to The Wall Street Journal. Along with Abridge \u2014\u00a0which has now raised $757.5 million total from investors, per Crunchbase \u2014 other well-funded startups in the AI healthcare documentation space include: Overall, funding to startups at the intersection of AI and healthcare hit $7.5 billion in 2024. * Rounds Raised By Startups Using AI, 2025 Artificial intelligence \u2022 Crypto \u2022 M&A \u2022 Regional \u2022 Seed funding \u2022 Startups \u2022 Venture",
      "url": "https://news.crunchbase.com/health-wellness-biotech/ai-doctor-note-taking-startup-abridge/"
    },
    {
      "title": "Abridge Business Breakdown & Founding Story - Contrary Research",
      "content": "In July 2025, the company raised $243 million in Series C funding at a $1.25 billion valuation, bringing its total funding to 320 million as of September 2025.",
      "url": "https://research.contrary.com/company/abridge"
    },
    {
      "title": "Abridge lands $300M funding round led by Andreessen Horowitz",
      "content": "Venture capital firms Andreessen Horowitz and Khosla Ventures led the round, the Pittsburgh-based startup announced yesterday, bringing Abridge\u2019s valuation to roughly $5.3 billion. Abridge\u2019s product, an AI tool that it says it hopes to reduce burnout by simplifying medical discussions with patients, will support around 50 million medical conversations this year, according to a blog post announcing the raise. Abridge has so far been at the top of Pittsburgh\u2019s venture capital raises in recent years, raking in nearly half of Pittsburgh\u2019s decade-high $689 million raised in Q1 2025. The most recent raise announcement comes after Abridge said in March that it was moving to hire in San Francisco, citing a need to hire \u201chundreds\u201d to meet current demand.",
      "url": "https://technical.ly/entrepreneurship/abridge-300m-healthtech-ai-funding/"
    },
    {
      "title": "Abridge Raises $250 Million in Series D - October 2024 - SalesTools",
      "content": "Abridge successfully raised **$250 Million** in this Series D funding round. **IVP (Institutional Venture Partners)** (Co-Lead Investor): Leading late-stage venture capital firm co-leading the round **Bessemer Venture Partners** (Investor): Long-term venture capital firm participating in the round Ventures** (Investor): Venture capital firm participating in the round **Lightspeed Venture Partners** (Investor): Multi-stage venture capital firm **NVentures (NVIDIA)** (Strategic Investor): NVIDIA's venture capital arm providing AI compute expertise **Redpoint Ventures** (Investor): Early-stage and growth venture capital firm **Spark Capital** (Investor): Technology-focused venture capital firm Entrepreneur and investor co-leading the Series D round Leading late-stage venture capital firm co-leading the round Long-term venture capital firm participating in the round Venture capital firm participating in the round Series D(258)NVIDIA(4)Healthcare AI(1)Clinical Documentation(1)Generative AI(1)EHR Integration(1)",
      "url": "https://salestools.io/report/abridge-raises-250-million-series-d-october-2024"
    }
  ],
  "raw_content": "\nHealthcare startup Abridge tops $5 billion valuation in A16z-led ...\nHealthcare firm Abridge, which uses artificial intelligence to build medical documents, has raised $300 million at a $5.3 billion valuation.\n\nAI Note-Taking Startup Abridge Raises $300M As Tech To Reduce ...\n# AI Note-Taking Startup Abridge Raises $300M As Tech To Reduce Physician Burnout Gains Traction Abridge, a startup that offers an AI note-taking tool for doctors, raised $300 million at a $5.3 billion valuation, according to The Wall Street Journal. Along with Abridge \u2014\u00a0which has now raised $757.5 million total from investors, per Crunchbase \u2014 other well-funded startups in the AI healthcare documentation space include: Overall, funding to startups at the intersection of AI and healthcare hit $7.5 billion in 2024. * Rounds Raised By Startups Using AI, 2025 Artificial intelligence \u2022 Crypto \u2022 M&A \u2022 Regional \u2022 Seed funding \u2022 Startups \u2022 Venture\n\nAbridge Business Breakdown & Founding Story - Contrary Research\nIn July 2025, the company raised $243 million in Series C funding at a $1.25 billion valuation, bringing its total funding to 320 million as of September 2025.\n\nAbridge lands $300M funding round led by Andreessen Horowitz\nVenture capital firms Andreessen Horowitz and Khosla Ventures led the round, the Pittsburgh-based startup announced yesterday, bringing Abridge\u2019s valuation to roughly $5.3 billion. Abridge\u2019s product, an AI tool that it says it hopes to reduce burnout by simplifying medical discussions with patients, will support around 50 million medical conversations this year, according to a blog post announcing the raise. Abridge has so far been at the top of Pittsburgh\u2019s venture capital raises in recent years, raking in nearly half of Pittsburgh\u2019s decade-high $689 million raised in Q1 2025. The most recent raise announcement comes after Abridge said in March that it was moving to hire in San Francisco, citing a need to hire \u201chundreds\u201d to meet current demand.\n\nAbridge Raises $250 Million in Series D - October 2024 - SalesTools\nAbridge successfully raised **$250 Million** in this Series D funding round. **IVP (Institutional Venture Partners)** (Co-Lead Investor): Leading late-stage venture capital firm co-leading the round **Bessemer Venture Partners** (Investor): Long-term venture capital firm participating in the round Ventures** (Investor): Venture capital firm participating in the round **Lightspeed Venture Partners** (Investor): Multi-stage venture capital firm **NVentures (NVIDIA)** (Strategic Investor): NVIDIA's venture capital arm providing AI compute expertise **Redpoint Ventures** (Investor): Early-stage and growth venture capital firm **Spark Capital** (Investor): Technology-focused venture capital firm Entrepreneur and investor co-leading the Series D round Leading late-stage venture capital firm co-leading the round Long-term venture capital firm participating in the round Venture capital firm participating in the round Series D(258)NVIDIA(4)Healthcare AI(1)Clinical Documentation(1)Generative AI(1)EHR Integration(1)\n",
  "count": 5,
  "success": true
}